SAB BIOTHERAPEUTICS, INC. (SABSW) Capital expenditures 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABSW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$933,156FY2025 · since FY2020: $12.7M → $933,156
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $933,156 | +176.7% |
| FY2024 | $337,262 | +71.1% |
| FY2023 | $197,154 | -90.9% |
| FY2022 | $2.2M | -80.2% |
| FY2021 | $10.9M | -14.0% |
| FY2020 | $12.7M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More SABSW financial trends
SABSW RevenueSABSW Net incomeSABSW Net marginSABSW Gross profitSABSW Gross marginSABSW Operating incomeSABSW Operating marginSABSW Operating cash flowSABSW Free cash flowSABSW Return on equitySABSW Stock buybacksSABSW Dividends paidSABSW Total assetsSABSW Total liabilitiesSABSW Shareholders’ equitySABSW overview →